Clinical trials: Wounds, Penetrating
Full-thickness Skin Defects, Degloving Injuries
RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction
A prospective randomized within-subject controlled study to compare the clinical performance of conventional autografting with and without the RECELL system on acute non-burn full-thickness skin defects.
- Conditions
- Full-thickness Skin Defects, Degloving Injuries, Crush Injuries, Laceration of Skin
- Trial name
- NCT04091672
- Testing
- Control Intervention (Conventional Autograft), Investigational Intervention (RECELL + more widely meshed autograft)
- Where
- 18 sites in United States
- Volunteers
- 65 people
- Sponsor
- Avita Medical
Neurobehavioral Disinhibition
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Participants With Traumatic Brain Injury
This is a multicenter, randomized, placebo-controlled study to evaluate AVP-786 for the treatment of neurobehavioral disinhibition including aggression, agitation, and irritability in participants with traumatic brain injury…
- Trial name
- NCT03095066
- Testing
- AVP-786-28, AVP-786-42.63
- Where
- 54 sites in United States
- Volunteers
- 168 people
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
Needle Stick
Simulated Clinical Use Testing on Safety Lancets (Test A)
A simulated clinical use testing on the HTL-Strefa's safety lancets
- Trial name
- NCT03807635
- Testing
- ergoLance safety lancet, Acti-Lance safety lancet
- Where
- 2 sites in United States
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- HTL-Strefa S.A.
Needle Stick
Simulated Clinical Use Testing On Safety Lancets (Test B)
A simulated clinical use testing on the HTL-Strefa's safety lancets
- Trial name
- NCT03811444
- Testing
- Haemolance Plus safety lancet, Prolance safety lancet, MediSafe Solo safety lancet
- Where
- 2 sites in United States
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- HTL-Strefa S.A.
Acute Aortic Dissection, Aortic Rupture
Thoraflex Hybrid Post-Market Study
This is a global, prospective non-interventional, multi-centre, post-market study of the Vascutek Thoraflex™ Hybrid system in patients with acute thoracic aortic syndrome, subacute/chronic dissection of the aorta and aortic…
- Conditions
- Acute Aortic Dissection, Aortic Rupture, Penetrating Aortic Ulcer, Aortic Dissection
- Trial name
- THOR (NCT03414866)
- Testing
- EQ-5D-5L QOL questionnaire
- Where
- 7 sites in Canada, Germany and 2 more
- Volunteers
- 182 people
- Sponsor
- Vascutek Ltd.
Wounds and Injuries
A Single Site Safety and Tolerability Study of HBOC-201 in Trauma Subjects
The main purpose of this study is to determine if HBOC-201 is safe and tolerable to trauma subjects, when given to treat the inadequate supply of blood and nutrients to tissues and organs.
- Trial name
- NCT00301483
- Testing
- Hemoglobin-based oxygen carrier-201 (HBOC 201), Standard of Care
- Where
- South Africa
- Volunteers
- 53 people
- Sponsor
- Biopure Corporation
Needle Stick
Simulated Clinical Use Testing on Safe'N'Sound 1ML Stalked Passive Delivery System With Add-On Extended Finger Flanges
A simulated clinical use testing the Save'N'Sound 1mL staked Passive Delivery System with add-on extended finger flanges
- Trial name
- NCT02663635
- Testing
- Safe'N'Sound
- Where
- United States
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Nemera La Verpilliere
Traumatic Brain Injury
Safety and Tolerability of Oxycyte in Patients With Traumatic Brain Injury (TBI)
The primary objective of this study is to evaluate the safety and tolerability of a single administration of Oxycyte in patients with severe non-penetrating traumatic brain injury (TBI).
- Trial name
- STOP-TBI (NCT00908063)
- Testing
- Oxycyte, Normal Saline
- Where
- 6 sites in Israel, Switzerland
- Volunteers
- 18 people
- Sponsor
- Tenax Therapeutics, Inc.
Needle Stick
Simulated Clinical Use Testing on the DropSafe Safety Pen Needle
A simulated clinical use testing on the DropSafe safety pen needle
- Trial name
- NCT03803488
- Testing
- DropSafe safety pen needle
- Where
- 2 sites in United States
- Volunteers
- 35 people, healthy volunteers welcome
- Sponsor
- HTL-Strefa S.A.
Sunburn
Dermal Penetration of the Titanium Dioxide in Anthelios SX SPF40 Cream
To determine the penetration of micronized and pigmentary TiO2 in Formulas 283419 2 and 760.001 into the stratum corneum of Compromised (Induced Sunburn) human skin via skin stripping of human subjects.
- Trial name
- NCT01021787
- Testing
- Titanium dioxide
- Where
- Canada
- Volunteers
- 26 people, healthy volunteers welcome
- Sponsor
- Loreal USA